EXPI
Get informed when a big investor buys or sells
+ FollowUndervalued by 254.3% based on the discounted cash flow analysis.
| Market cap | $782.01 Million |
|---|---|
| Enterprise Value | $729.84 Million |
| Dividend Yield | $0.20 (4.07%) |
| Earnings per Share | $-0.14 |
| Beta | 2.2 |
| Outstanding Shares | 162,017,200 |
| P/E Ratio | -47.39 |
|---|---|
| PEG | 88.15 |
| Price to Sales | 0.16 |
| Price to Book Ratio | 4.73 |
| Enterprise Value to Revenue | 0.15 |
| Enterprise Value to EBIT | -35.37 |
| Enterprise Value to Net Income | -44 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.27 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1716▼ 13.07% |
|---|---|
| Total Calls | 60,600▼ 62.62% |
| Total Puts | 10,400▼ 78.78% |
Holdings and activity of institutional investors.
| Ownership % | 38.32%▼ 1.78% |
|---|---|
| Total Invested | $366.43M▼ 35.72% |
| Investors Holding | 230▲ 1.00% |
No data
Provides critical analysis and revenue estimates for tax legislation, directly influencing corporate tax structures and excise taxes highly relevant to tobacco manufacturing.
Controls tax policy (including excise taxes on tobacco), trade policy, and tariffs, all of which profoundly impact the profitability and operational costs of tobacco manufacturers.
Directly regulates the FDA, which has extensive oversight over tobacco product manufacturing, marketing, and labeling; also impacts labor costs through labor law oversight.
Oversees antitrust laws, intellectual property, and major litigation, all of which are highly relevant to the competitive landscape and product development in the tobacco industry.
Extensive jurisdiction over interstate commerce, consumer protection (FTC), and advertising practices, which are highly critical for the tobacco manufacturing industry.